Inozyme Pharma, Inc.

Inozyme Pharma, Inc.

INZY
Inozyme Pharma, Inc.US flagNASDAQ Global Select
4.00
USD
+0.01
- -
258.25MMarket Cap

Income Statement (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
- Operating Expenses
12
21
57
57
69
76
104
+ Selling, General & Admin
3
5
11
19
21
21
21
+ Research & Development
8
16
46
38
48
55
83
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-12
-21
-57
-57
-69
-76
-104
- Non-Operating (Income) Loss
-5
-1
-1
- -
-2
-4
-2
+ Interest Expense, Net
- -
-1
- -
- -
-2
-5
-2
+ Interest Expense
- -
- -
- -
- -
- -
3
6
- Interest Income
- -
1
- -
- -
2
8
8
+ Other Non-Op (Income) Loss
-4
- -
- -
- -
- -
- -
- -
Pretax Income
-7
-20
-56
-57
-67
-71
-102
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-7
-20
-56
-57
-67
-71
-102
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-7
-20
-56
-57
-67
-71
-102
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-7
-20
-56
-57
-67
-71
-102
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-7
-20
-56
-57
-67
-71
-102
EBIT
-12
-21
-57
-57
-69
-76
-104
EBITDA
-12
-21
-57
-56
-68
-75
-103
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
EBITA
-12
-21
-57
-57
-69
-76
-104
Gross Margin (%)
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
1
1
1
1
Basic Weighted Avg Shares
15
15
11
24
38
52
- -
Basic EPS, GAAP
-0.46
-1.3
-5.11
-2.4
-1.78
-1.37
- -
Basic EPS from Cont Ops
-0.46
-1.3
-5.11
-2.4
-1.78
-1.37
- -
Diluted Weighted Avg Shares
15
15
11
24
38
52
- -
Diluted EPS, GAAP
-0.46
-1.3
-5.11
-2.4
-1.78
-1.37
- -
Diluted EPS from Cont Ops
-0.46
-1.3
-5.11
-2.4
-1.78
-1.37
- -

Balance Sheet (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
Total Current Assets
43
47
151
115
131
196
121
+ Cash, Cash Equivalents & STI
43
47
148
112
128
189
113
+ Cash & Cash Equivalents
36
32
28
23
33
35
21
+ ST Investments
7
16
120
88
95
154
92
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
- -
3
3
3
7
7
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
- -
18
8
8
5
3
+ Property, Plant & Equip, Net
- -
- -
3
4
4
3
1
+ Property, Plant & Equip
- -
- -
3
5
5
5
4
- Accumulated Depreciation
- -
- -
- -
1
2
2
3
+ LT Investments & Receivables
- -
- -
12
- -
- -
- -
- -
+ LT Investments
- -
- -
12
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
4
4
4
2
1
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
4
4
4
2
1
Total Assets
44
48
169
124
139
201
123
+ Payables & Accruals
2
3
10
11
14
14
18
+ Accounts Payable
1
1
3
2
3
1
3
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
1
2
7
9
11
13
16
+ ST Debt
- -
- -
- -
1
1
1
15
+ ST Borrowings
- -
- -
- -
- -
- -
- -
15
+ ST Finance Leases
- -
- -
- -
1
1
1
1
+ Other ST Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
- -
- -
- -
- -
- -
Total Current Liabilities
2
3
10
12
15
15
34
+ LT Debt
- -
- -
1
3
6
46
31
+ LT Borrowings
- -
- -
- -
- -
4
45
31
+ LT Finance Leases
- -
- -
1
3
2
1
- -
+ Other LT Liabilities
55
78
- -
- -
- -
- -
- -
+ Accrued Liabilities
- -
- -
1
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
55
78
-1
- -
- -
- -
- -
Total Noncurrent Liabilities
55
78
1
3
6
46
31
Total Liabilities
57
81
11
14
21
60
65
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
1
1
249
257
333
426
446
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
1
1
249
257
333
426
446
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-15
-35
-91
-148
-215
-286
-388
+ Other Equity
- -
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
-14
-33
158
109
118
140
58
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
Total Equity
-14
-33
158
109
118
140
58
Total Liabilities & Equity
44
48
169
124
139
201
123
Shares Outstanding
20
20
23
24
40
62
64
Number of Employees
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
1
3
3
2
1
Net Debt
-36
-32
-28
-23
-29
10
25
Net Debt to Equity
259.21
95.14
-17.74
-21.34
-24.31
7.25
43.02
Tangible Common Equity Ratio
-31.87
-69.29
93.35
88.45
85.06
69.94
46.94
Current Ratio
18.11
14.67
15.14
9.92
8.93
13.36
3.56
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
+ Net Income
-7
-20
-56
-57
-67
-71
-102
+ Depreciation & Amortization
- -
- -
- -
1
1
1
1
+ Non-Cash Items
-4
- -
20
8
7
3
5
+ Stock-Based Compensation
- -
- -
2
7
8
7
8
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
18
- -
- -
- -
- -
+ Other Non-Cash Adj
-4
- -
- -
1
-1
-4
-3
+ Chg in Non-Cash Work Cap
1
1
- -
- -
2
-3
5
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
-3
- -
- -
-2
1
+ Inc (Dec) in Accts Payable
2
1
6
1
3
- -
5
+ Inc (Dec) in Other
- -
- -
-3
-1
-1
-1
-1
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-9
-19
-36
-48
-58
-71
-92
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
-1
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
-1
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
116
- -
56
86
11
+ Increase in Capital Stock
- -
- -
116
- -
56
86
11
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
9
-8
-117
43
-5
-53
67
+ Dec in LT Investment
23
16
61
165
147
216
222
+ Inc in LT Investment
-14
-25
-178
-122
-152
-269
-155
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
9
-8
-117
43
-5
-54
67
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
- -
4
40
- -
+ Cash From Debt
- -
- -
- -
- -
4
40
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
32
23
34
1
13
- -
1
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
32
23
150
1
73
126
11
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
32
-4
-3
-5
10
2
-14
EBITDA
-12
-21
-57
-56
-68
-75
-103
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow
-10
-19
-37
-49
-58
-71
-92
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-19
-37
-49
-54
-31
-92
Free Cash Flow per Basic Share
-0.64
-1.25
-3.31
-2.06
-1.54
-1.37
- -
Price/Free Cash Flow
- -
- -
-6.43
-3.36
-0.69
-3.14
- -
Cash Flow to Net Income
1.36
0.95
0.64
0.85
0.86
0.99
0.9
Capital Expenditures
- -
- -
-1
- -
- -
- -
- -